If you enjoy this content, please share it with a colleague
Mirada Medical Ltd.
RELATED CONTENT
Mirada Medical announced it will showcase its latest solutions for radiotherapy, including RTx and Workflow Box, at the European Society for Radiation Oncology (ESTRO) 2016 Congress, April 29-May 2 in Torino, Italy.
Mirada Medical announced a new agreement to work with the clinicians and physicists at The Christie Hospital in Manchester, England, a world-renowned centre for complete cancer care.
Mirada Medical Ltd has announced that its XD3 Advanced image review and analysis software is being deployed by Alliance Medical in partnership with 30 National Health Service (NHS) hospital positron emission tomography/computed tomography (PET/CT) departments nationwide.
Mirada Medical Ltd, a medical imaging software company, and BTG plc, a global specialist healthcare company, announced a collaboration to develop dosimetry software solutions to optimize radioembolization therapy with TheraSphere.
Mirada Medical and collaborators from the University Medical Center, Groningen, The Netherlands, will present new research on quality assurance of deformable image registration (DIR) at the annual meeting of the American Association of Medical Physicists (AAPM). Accurate definition of targets and critical structures is essential for the planning and delivery of radiation therapy and radiosurgery. DIR is increasingly utilized during treatment planning to aid in this process.
Mirada Medical and Nautilus Medical have announced their agreement to provide the portable Mirada PET/CT viewer to existing and future Nautilus Medical customers for their CD/DVD DICOM distribution systems.
State-of-the-art deformable image registration and multimodality imaging techniques continue to drive advances in radiation therapy clinical practice. Novel research into the utility and benefit of such advanced techniques are the topics that the Mirada Medical scientific team and collaborators presented at the 3rd ESTRO (European Society for Radiotherapy and Oncology) forum conference, April 24-28 in Barcelona, Spain.
Mirada Medical software applied to state-of-the-art adaptive radiotherapy (ART) was the subject of an oral presentation at the annual conference of the American Society for Radiation Oncology (ASTRO), Sept. 14-17 in San Francisco.
September 24, 2014 — Mirada Medical software applied to state-of-the-art adaptive radiotherapy (ART) was the subject of an oral presentation at the annual conference of the American Society for Radiation Oncology (ASTRO) earlier this month in San Francisco.
Mirada Medical introduced its Registration Assurance program at the 2014 annual meeting of the American Association of Physicists in Medicine (AAPM) in Austin, Texas, to give clinicians total confidence in deformable registration as they integrate it into clinical practice.